HomeCompareADGI vs XYLD

ADGI vs XYLD: Dividend Comparison 2026

ADGI yields 43.10% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADGI wins by $248.9K in total portfolio value
10 years
ADGI
ADGI
● Live price
43.10%
Share price
$4.64
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$274.2K
Annual income
$49,280.46
Full ADGI calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — ADGI vs XYLD

📍 ADGI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADGIXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADGI + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADGI pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADGI
Annual income on $10K today (after 15% tax)
$3,663.79/yr
After 10yr DRIP, annual income (after tax)
$41,888.39/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, ADGI beats the other by $39,152.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADGI + XYLD for your $10,000?

ADGI: 50%XYLD: 50%
100% XYLD50/50100% ADGI
Portfolio after 10yr
$149.7K
Annual income
$26,249.74/yr
Blended yield
17.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADGI right now

ADGI
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
4.2
Piotroski
2/9
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADGI buys
0
XYLD buys
0
No recent congressional trades found for ADGI or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADGIXYLD
Forward yield43.10%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$274.2K$25.3K
Annual income after 10y$49,280.46$3,219.02
Total dividends collected$210.7K$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: ADGI vs XYLD ($10,000, DRIP)

YearADGI PortfolioADGI Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$15,010$4,310.34$10,818$1,098.39+$4.2KADGI
2$22,108$6,046.71$11,738$1,222.51+$10.4KADGI
3$31,979$8,323.18$12,774$1,364.64+$19.2KADGI
4$45,469$11,251.72$13,944$1,527.86+$31.5KADGI
5$63,603$14,951.67$15,270$1,715.87+$48.3KADGI
6$87,602$19,546.64$16,775$1,933.09+$70.8KADGI
7$118,895$25,160.75$18,490$2,184.87+$100.4KADGI
8$159,132$31,914.57$20,450$2,477.63+$138.7KADGI
9$210,192$39,920.85$22,697$2,819.19+$187.5KADGI
10$274,186$49,280.46$25,280$3,219.02+$248.9KADGI

ADGI vs XYLD: Complete Analysis 2026

ADGIStock

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

Full ADGI Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this ADGI vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADGI vs SCHDADGI vs JEPIADGI vs OADGI vs KOADGI vs MAINADGI vs QYLDADGI vs JEPQADGI vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.